v3.24.2.u1
Condensed Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Thousands
Total
Total Stockholders’ Equity attributable to Privia Health Group, Inc.
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Non-controlling Interest
Beginning balance (in shares) at Dec. 31, 2022     114,690,808      
Beginning balance at Dec. 31, 2022 $ 519,049 $ 499,094 $ 1,148 $ 714,639 $ (216,693) $ 19,955
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock upon exercise of stock options and vesting of restricted stock units (in shares)     779,153      
Issuance of common stock upon exercise of stock options and vesting of restricted stock units 1,477 1,477 $ 11 1,466    
Stock-based compensation expense 5,381 5,381   5,381    
Contributed non-controlling interest 24,212         24,212
Net income (loss) 6,402 7,324     7,324 (922)
Ending balance (in shares) at Mar. 31, 2023     115,469,961      
Ending balance at Mar. 31, 2023 556,521 513,276 $ 1,159 721,486 (209,369) 43,245
Beginning balance (in shares) at Dec. 31, 2022     114,690,808      
Beginning balance at Dec. 31, 2022 519,049 499,094 $ 1,148 714,639 (216,693) 19,955
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 12,762          
Ending balance (in shares) at Jun. 30, 2023     117,106,892      
Ending balance at Jun. 30, 2023 571,309 525,232 $ 1,171 726,156 (202,095) 46,077
Beginning balance (in shares) at Mar. 31, 2023     115,469,961      
Beginning balance at Mar. 31, 2023 556,521 513,276 $ 1,159 721,486 (209,369) 43,245
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock upon exercise of stock options and vesting of restricted stock units (in shares)     1,636,931      
Issuance of common stock upon exercise of stock options and vesting of restricted stock units 4,306 4,306 $ 12 4,294    
Stock-based compensation expense 9,247 9,247   9,247    
Repurchase of non-controlling interest (5,694) (8,871)   (8,871)   3,177
Contributed non-controlling interest 569         569
Net income (loss) 6,360 7,274     7,274 (914)
Ending balance (in shares) at Jun. 30, 2023     117,106,892      
Ending balance at Jun. 30, 2023 $ 571,309 525,232 $ 1,171 726,156 (202,095) 46,077
Beginning balance (in shares) at Dec. 31, 2023 118,216,979   118,216,979      
Beginning balance at Dec. 31, 2023 $ 607,389 561,437 $ 1,182 753,869 (193,614) 45,952
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock upon exercise of stock options and vesting of restricted stock units (in shares)     461,923      
Issuance of common stock upon exercise of stock options and vesting of restricted stock units 475 475 $ 5 470    
Stock-based compensation expense 11,904 11,904   11,904    
Net income (loss) 3,056 2,984     2,984 72
Ending balance (in shares) at Mar. 31, 2024     118,678,902      
Ending balance at Mar. 31, 2024 $ 622,824 576,800 $ 1,187 766,243 (190,630) 46,024
Beginning balance (in shares) at Dec. 31, 2023 118,216,979   118,216,979      
Beginning balance at Dec. 31, 2023 $ 607,389 561,437 $ 1,182 753,869 (193,614) 45,952
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) $ 7,699          
Ending balance (in shares) at Jun. 30, 2024 119,479,134   119,479,134      
Ending balance at Jun. 30, 2024 $ 643,607 595,407 $ 1,194 781,376 (187,163) 48,200
Beginning balance (in shares) at Mar. 31, 2024     118,678,902      
Beginning balance at Mar. 31, 2024 622,824 576,800 $ 1,187 766,243 (190,630) 46,024
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock upon exercise of stock options and vesting of restricted stock units (in shares)     800,232      
Issuance of common stock upon exercise of stock options and vesting of restricted stock units 749 749 $ 7 742    
Stock-based compensation expense 14,391 14,391   14,391    
Contributed non-controlling interest 1,000         1,000
Net income (loss) $ 4,643 3,467     3,467 1,176
Ending balance (in shares) at Jun. 30, 2024 119,479,134   119,479,134      
Ending balance at Jun. 30, 2024 $ 643,607 $ 595,407 $ 1,194 $ 781,376 $ (187,163) $ 48,200